APM
CMPX icon

Avidity Partners Management’s Compass Therapeutics CMPX Stock Holding History

Avidity Partners Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,599,600
Closed -$2.5M – 98
2023
Q4 		$2.5M Hold
1,599,600
– – 0.1% 69
2023
Q3 		$3.15M Sell
1,599,600
-20,600
-1% -$50.9K 0.13% 77
2023
Q2 		$5.15M Sell
1,620,200
-204,800
-11% -$643K 0.18% 81
2023
Q1 		$5.97M Sell
1,825,000
-175,000
-9% -$687K 0.2% 70
2022
Q4 		$10.1M Hold
2,000,000
– – 0.24% 60
2022
Q3 		$4.56M Hold
2,000,000
– – 0.1% 81
2022
Q2 		$5.3M Hold
2,000,000
– – 0.12% 58
2022
Q1 		$2.74M Hold
2,000,000
– – 0.06% 83
2021
Q4 		$6.34M Buy
+2,000,000
New +$6.63M 0.13% 73

Other funds holding CMPX

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return